Answer
Tzield (teplizumab) is administered by intravenous infusion over at least 30 minutes once daily for 14 consecutive days, using body-surface-area-based dosing, with no two doses given on the same day.
Sources for this answer
- Tzield 2 mg/2 mL concentrate for solution for infusionSANOFI · emc · SmPC §4.2 Posology and method of administration · Version 1Document updated
Sources checked